Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine

被引:187
作者
Chen, LY
Haught, WH
Yang, BC
Saldeen, TGP
Parathasarathy, S
Mehta, JL
机构
[1] UNIV FLORIDA, COLL MED, DEPT MED, GAINESVILLE, FL 32610 USA
[2] DEPT VET AFFAIRS MED CTR, GAINESVILLE, FL USA
[3] UNIV UPPSALA, DEPT FORENS MED, S-75105 UPPSALA, SWEDEN
[4] EMORY UNIV, SCH MED, DEPT OBSTET & GYNECOL, ATLANTA, GA 30322 USA
关键词
D O I
10.1016/S0735-1097(97)00158-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We sought to document the common mechanisms of the antiatherogenic effects of the cholesterol-lowering hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor lovastatin, the dihydropyridine Ca2+ blocker amlodipine and the antioxidant vitamin E. Background. Vitamin E, HMG-CoA reductase inhibitors and Ca2+ blockers each inhibit atherosclerosis in hypercholesterolemic animals. Methods. New Zealand White rabbits were fed regular chow (Group A), chow with 1% cholesterol (Group B), 1% cholesterol diet plus lovastatin (Group C), 1% cholesterol diet plus vitamin E (Group D) or 1% cholesterol diet plus amlodipine (Group E) for 12 weeks. The extent of aortic atherosclerosis was measured by planimetry of the sudanophilic area, Malondialdehyde (MDA) and superoxide dismutase (SOD) in blood were measured as indexes of lipid peroxidation and antioxidant activity, respectively. Results. Group A rabbits showed no atherosclerosis, whereas Group B rabbits had 17.4 +/- 9.3% (mean +/- SD) of the aorta covered nith atherosclerosis, and Groups C, D and E rabbits had significantly less atherosclerosis, Plasma SOD activity was lower in Group B than in Group A (6.9 +/- 1.1 vs. 12.8 +/- 1.5 U/ml, p < 0.01) and was preserved in the groups given lovastatin, vitamin E or amlodipine with a high cholesterol diet. The serum MDA level was higher in Group B rabbits than Group A rabbits (12.1 +/- 2.6 vs. 1.2 +/- 0.1 nmol/ml, p < 0.01) and increased minimally in rabbits given lovastatin, vitamin E or amlodipine with a high cholesterol diet. In in vitro experiments, both lovastatin and amlodipine preserved SOD activity and reduced the oxidizability of low density lipoproteins by rabbit leukocytes. Conclusions. This study suggests that a reduction in lipid peroxidation and preservation of SOD may be common mechanisms of antiatherosclerotic effects of lovastatin, vitamin E and amlodipine. (C) 1997 by the American College of Cardiology.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 40 条
[1]   LOVASTATIN INHIBITS LOW-DENSITY-LIPOPROTEIN OXIDATION AND ALTERS ITS FLUIDITY AND UPTAKE BY MACROPHAGES - INVITRO AND INVIVO STUDIES [J].
AVIRAM, M ;
DANKNER, G ;
COGAN, U ;
HOCHGRAF, E ;
BROOK, JG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (03) :229-235
[2]  
BALL RY, 1988, BRIT J EXP PATHOL, V69, P43
[3]   LOW-DENSITY-LIPOPROTEIN INHIBITS ACCUMULATION OF NITRITES IN MURINE BRAIN ENDOTHELIAL-CELL CULTURES [J].
BERETA, M ;
BERETA, J ;
COHEN, S ;
COHEN, MC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (01) :315-320
[4]  
BIERENBAUM ML, 1992, BIOCHEM INT, V28, P57
[5]   ISOPRENOID METABOLISM IS REQUIRED FOR STIMULATION OF THE RESPIRATORY BURST OXIDASE OF HL-60 CELLS [J].
BOKOCH, GM ;
PROSSNITZ, V .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :402-408
[6]   LIPIDS AND OXIDIZED LIPIDS IN HUMAN ATHEROSCLEROTIC LESIONS AT DIFFERENT STAGES OF DEVELOPMENT [J].
CARPENTER, KLH ;
TAYLOR, SE ;
VANDERVEEN, C ;
WILLIAMSON, BK ;
BALLANTINE, JA ;
MITCHINSON, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1256 (02) :141-150
[7]   INVITRO INHIBITION OF ALLERGIC HISTAMINE-RELEASE BY CALCIUM-ANTAGONISTS [J].
CHAND, N ;
PILLAR, J ;
DIAMANTIS, W ;
SOFIA, RD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 107 (03) :353-358
[8]  
ESTERBAUER H, 1987, J LIPID RES, V28, P495
[9]   THE INHIBITION OF LIPID-PEROXIDATION BY CINNARIZINE - POSSIBLE IMPLICATIONS TO ITS THERAPEUTIC AND SIDE-EFFECTS [J].
FERNANDES, AC ;
FILIPE, PM ;
COELHO, H ;
MANSO, CF .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (05) :709-714
[10]   SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES [J].
GIROUX, LM ;
DAVIGNON, J ;
NARUSZEWICZ, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1165 (03) :335-338